Skip to content

An efficacy evaluation of hair oil for hair fall reduction, growth and strengthening of hair in healthy Indian human volunteers

An efficacy evaluation of hair oil for hair fall reduction, growth and strengthening of hair in healthy Indian human volunteers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/10/004079
Enrollment
60
Registered
2013-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Herb enriched oil formulation (DRDC/2013/006): The Study will be conducted for a period of approximately 12 weeks for each subject and will be evaluated at baseline, 4, 8 and 12 weeks f

Sponsors

Dabur India Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Subjects in general good health. •Subjects in the age group 18-45 years (both the ages inclusive) •Subjects willing to give a written informed consent and agree to come for a regular follow up visit. •Subjects complaining of hair loss, hair fall and damage •Subjects willing to abide by and comply with the study protocol. •Subjects who have not participated in a similar investigation in the past four weeks. •Subjects who have not used hair oil in past 2 weeks •Subjects who have not undergone any hair therapy in minimum 3 months •Healthy volunteers with no known allergy to any of the test ingredients •Subjects who show no sensitivity to test product. •Subjects who are not on dieting. •Subjects who are willing to refrain from using dyes/henna/hair treatment throughout the study. •Subjects willing not to tie hair tightly.

Exclusion criteria

Exclusion criteria: •Subjects who are undergoing hair growth or hair straightening or transplant treatment 3 months before screening into the study •Subjects who have diseased Scalp conditions at the time of screening. •Subjects who have alopecia areata •Subjects who have treatments of chemotherapy within 6 months before starting study •Subjects who have history of addiction or drug abuse or psychiatric disorder •Subjects who use hairpiece during study terms •Subjects on oral medications or suffering from chronic illness which will compromise the study. •Subjects who are pregnant lactating or nursing •Subjects participating in other similar cosmetic or therapeutic trial. •Any underlying uncontrolled medical illness

Design outcomes

Primary

MeasureTime frame
Improvement in hair growth,reduction of hair fall and strength of hair in comparison to baseline as determined by Dermatological assessmentTimepoint: 12 weeks

Secondary

MeasureTime frame
â?¢Safety of Investigational product by dermatologist and subjects. â?¢Improvement in overall condition of hair as assessed by dermatological and subject Timepoint: 12 weeks

Countries

India

Contacts

Public ContactDr Arun Gupta

MS Clinical Research Pvt.Ltd

rachana.shilpakar@mscr.in8040917253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026